How should I manage a patient with severe hyponatremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Severe Hyponatremia (Sodium 3.4 mmol/L)

A sodium level of 3.4 mmol/L represents a critical medical emergency requiring immediate aggressive correction with hypertonic saline to prevent cerebral edema, seizures, and death. 1

Initial Assessment and Treatment

  • Severe hyponatremia (Na <125 mmol/L) with neurological symptoms requires emergency infusion of 3% hypertonic saline 1, 2
  • For patients with severe symptomatic hyponatremia, administer 100-150 mL bolus of 3% hypertonic saline 1, 3
  • Target initial correction of 6 mmol/L over 6 hours or until severe symptoms resolve 1
  • Total correction should not exceed 8-10 mmol/L in 24 hours to prevent osmotic demyelination syndrome 1, 4
  • Monitor serum sodium every 4-6 hours during initial correction 1

Hospital-Based Management

  • Initiate treatment in a hospital setting where serum sodium can be closely monitored 4
  • Too rapid correction (>12 mEq/L/24 hours) can cause osmotic demyelination resulting in dysarthria, mutism, dysphagia, lethargy, seizures, coma and death 4
  • In susceptible patients (those with malnutrition, alcoholism, or advanced liver disease), slower rates of correction are advisable 4

Ongoing Management After Initial Stabilization

  • After initial emergency correction, determine the underlying cause of hyponatremia to guide further management 2
  • For hypovolemic hyponatremia: administer normal saline infusions 2
  • For euvolemic hyponatremia: consider fluid restriction, salt tablets, or vaptans 2
  • For hypervolemic hyponatremia: treat the underlying cause (heart failure, cirrhosis) and restrict free water 2

Medication Considerations

  • Tolvaptan may be considered for euvolemic or hypervolemic hyponatremia once the patient is stabilized 4, 3
  • Tolvaptan should only be initiated in a hospital setting with close monitoring of serum sodium 4
  • Do not use tolvaptan in patients with hypovolemic hyponatremia 4
  • Monitor for hyperkalemia when using oral sodium supplements, especially in patients with renal impairment 1

Avoiding Complications

  • Never exceed correction of 8 mmol/L in 24 hours for chronic hyponatremia 1, 4
  • Monitor for signs of osmotic demyelination syndrome, which can occur with too rapid correction 4
  • After initial correction, if overcorrection is occurring, consider administering hypotonic fluids or desmopressin 3
  • Avoid fluid restriction during the first 24 hours of therapy with tolvaptan 4

Special Considerations

  • In patients with cirrhosis and hyponatremia, fluid restriction to 1-1.5 L/day is recommended for severe hyponatremia 5
  • In neurosurgical patients, hypertonic saline should be limited to severely symptomatic cases 1
  • The risk of overcorrection is higher in severely symptomatic patients; monitor diuresis closely as it correlates with sodium overcorrection 1

Remember that a sodium level of 3.4 mmol/L is incompatible with life and likely represents a critical laboratory error that requires immediate verification before treatment. If confirmed, this represents an extreme medical emergency requiring immediate intensive care management.

References

Guideline

Oral Sodium Supplementation in Hyponatremia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hyponatraemia-treatment standard 2024.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.